Linda Bowen
Head of Regulatory Policy and Intelligence, Seattle Genetics; Assistant Professor, RAQA Program, Temple University
DIA Inspire Award Winner
Q&A
When did you realize you wanted to work as a regulatory professional?
I became interested in regulatory affairs while working in Quality Assurance. I ate lunch with the regulatory group and they attempted to explain what they did, and back then (in 1992) most regulatory affairs professionals were generalists, so what they did was…everything! I decided to attend evening classes for my Master’s Degree in Drug Regulatory Affairs, and the company I worked for at the time, Block Drug Company, gave me an opportunity to move to the International RA department while still in school. That was 26 years ago. My first submission was a NCE for the Australian market, so I had a lot of learning to do in a short period of time.
In your opinion, what is the greatest challenge in your field?
With the incorporation of automation into day-to-day regulatory processes, how can we prepare regulatory professionals to become strategic and critical thinkers with less of a focus on the operational side? Are we preparing RA professionals with the right skills
What do you like most and least about your job?
What I love about my job is that I am challenged in new and different ways on a daily basis. What I dislike most about my position is that it is very hard for me to disconnect from the regulatory world. I am an information junkie. I am always afraid that I'll miss some important piece of information that will affect the company. Of course I know that won't happen, and as I get older I am learning how to take time for myself and my family on weekends, holidays, and vacation.
What is the first book you remember reading?
I was fascinated in grade school by the Encyclopedia Brown series of books. The first one I recall reading was, “Encyclopedia Brown Gets His Man.” The lead character in those books was Leroy “Encyclopedia” Brown, a child detective who solved neighborhood mysteries. Ironic that I would end up working in Regulatory Intelligence where we put our detective skills to work every day!
What advice would you give your younger self about to enter the “real world?”
To take advantage of every learning opportunity that presents itself. Repurposed skills from my days in Quality Assurance have presented themselves multiple times in my regulatory affairs career. And never be afraid to ask questions.
Imagine a day without work, the internet, and any other obligations. What would you do?
Visit close friends and relatives. As we get older, they are the constant in our lives.
Who would you have over for a dinner party, and what would you talk to them about?
My parents. I lost both of them to cancer, and there are so many things I would like to have discussed with them before they passed.
How has DIA helped you?
Specialty communities, such as the one I chair (Regulatory Affairs) are important to the membership of DIA. It helps build acumen, your network, and in my case, leadership skills. The communities provide an open forum to share best practices and discuss non-proprietary ideas and processes that support activities for emerging issues. With many members facing limited resources to travel or attend conferences, active participation in our community, and communities in general, is a great way to stay current with no additional costs–making the most of your DIA membership and network.
BIOGRAPHY
Linda Bowen, MS, RAC (US, EU, CAN), FRAPS, has more than 35 years of experience in the BioPharma Industry, of which 25 years were spent in regulatory affairs. She is Head of Regulatory Policy and Intelligence at Seattle Genetics and is an Assistant Professor in the Temple University RAQA Program. She was previously Head of US Regulatory Policy & Intelligence at Sanofi and has held regulatory positions at Bayer and GSK.
Linda is Chair of the DIA Regulatory Affairs Community and founder of the DIA Regulatory Intelligence Working Group. She was previously honored with the DIA’s 2012 Excellence in Volunteer Leadership Award. She is a past two-term member of the RAPS Board of Directors, Chair of the NJ/NY RAPS Chapter, and a RAPS Fellow. She is Program Chair for the 2019 RAPS Annual Convergence.
DIA Spotlights
-
Jonathan Andrus • Chief Business Officer, Clinical Ink
DIA Inspire Award Winner -
Catherine Baldridge • Principal Consultant & Owner, Essential Pharmacovigilance, LLC
DIA Community Leadership Council -
Kimberly Belsky • Executive Director, Regulatory Policy & Intelligence, Mallinckrodt Pharmaceuticals
DIA AdPromo Working Group Chair, DIA Regulatory Affairs Community -
Megan Bettle • Director, Centre for Regulatory Excellence, Statistics and Trials
Regional Editor Global Forum -
Stella Blackburn • Vice President, Global Head of Early Access and Risk Management, IQVIA
DIA Volunteer -
Poonam Bordoloi • Medical Affairs Team Lead, General Medicines, Global Scientific Content, Merck & Co., Inc.
DIA Volunteer -
Linda Bowen • Head of Regulatory Policy and Intelligence, Seattle Genetics; Assistant Professor, RAQA Program, Temple University
DIA Inspire Award Winner -
Joan Buenconsejo • Director and Biometrics Team Leader, Astra Zeneca
DIA Statistics Community Chair -
Gerald Dal Pan • Director, Office of Surveillance & Epidemiology, FDA’s Center for Drug Evaluation and Research
DIA Fellow -
Gaby Danan • former EU QPPV, Sanofi
DIA Fellow -
Richard Day • Professor of Clinical Pharmacology; University of New South Wales, Medicine, St. Vincent's Hospital
Fellow of DIA
Associate Editor TIRS
Regional Editor Global Forum -
Nancy Dreyer • Chief Scientific Officer and Senior Vice President, IQVIA
Fellow of DIA
DIA Inspire Award Winner -
E. Stewart Geary • Chief Medical Officer and a Senior Vice President, Eisai Co., Ltd.
DIA Fellow -
Alberto Grignolo • Corporate Vice President, Parexel
Fellow of DIA
Editor-in-Chief Global Forum -
Terry Katz • Head, Data Management and Statistics, Merck Animal Health
DIA GCP-QA Community Chair -
Agnes Klein • Senior Medical Advisor, Biologic and Radiopharmaceutical Drugs Directorate, Health Canada
DIA Volunteer -
Mark Kryah • Senior Advisor and COO, Pharmaceutical Project Management, Immunology, Eli Lilly and Company
DIA Project Management Community Chair -
Birka Lehmann • Senior Expert, Drug Regulatory Affairs; Lecturer, Friedrich Wilhelm University
Fellow of DIA -
Munish Mehra • Principal Biostatistician & Executive Director, Tigermed
DIA Inspire Award Winner
DIA Clinical Research Community Chair -
Lisa Mulcahy • Owner and Principal Consultant, Mulcahy Consulting, LLC
DIA Document and Records Management Community Chair -
Noriaki Murao • Short Term Consultant, World Health Organization, Western Pacific Region
DIA Fellow -
Robert Paarlberg • Principal, Paarlberg & Associates LLC
DIA Inspire Award Winner -
Kim Quaintance-Lunn • Vice President and Head, Regulatory Policy, North American Regulatory Affairs, Bayer
DIA Inspire Award Winner -
Matthew Reaney • Scientific Lead, Patient Centered Endpoints, IQVIA
DIA Study Endpoints Community Chair -
Jeffrey Sherman • Chief Medical Officer and Executive Vice President, Horizon Therapeutics
Fellow of DIA -
Meredith Smith • Director, Risk Management, Alexion Pharmaceuticals, Inc.; Adjunct Professor, School of Pharmacy, University of Southern California, Los Angeles
DIA Volunteer -
Ling Su • Professor and Director, Institute of Drug Regulatory Science, Shenyang Pharmaceutical University; Venture Partner, Lilly Asia Ventures
Fellow of DIA -
Angela van der Salm • Director Pharmacovigilance, Managing Partner, DADA Consultancy
DIA Volunteer -
Casey Walker • PGY-1 Behavioral Health Pharmacy Resident, University of the Sciences of Philadelphia
DIA Inspire Award Winner -
Jingsong Wang • CEO, Harbour BioMed
DIA Inspire Award Winner -
Richard C. Zink • Senior Director, Data Management and Statistics, TARGET PharmaSolutions
Associate Editor Therapeutic Innovation & Regulatory Science
